SAU:4163

Al-Dawaa Medical Services Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 13:43 UTC

Last close

n/aSAR

Market data

  • 9.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed
    • Computed from the filing for 2025
  • 12.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 4.8%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 7.6%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.58Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 6.7%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed

All from 100

lens 2 of 9

Sales

200
2017-12-31 to 2025-12-31100 at the start200
Sales: 100.00 on 2017-12-31 to 199.55 on 2025-12-31, up 100%.

Profit

266
2017-12-31 to 2025-12-31100 at the start266
Profit: 100.00 on 2017-12-31 to 266.14 on 2025-12-31, up 166%.

Shares in issue

42,448
2019-12-31 to 2025-12-31100 at the start42,448
Shares in issue: 100.00 on 2019-12-31 to 42448.00 on 2025-12-31, up 42348%.

Sales is at 200, Profit is at 266, Shares in issue is at 42448, against 100 in 2017.

Sales is at 200, Profit is at 266, Shares in issue is at 42448, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales, where the first year is 100200
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Profit, where the first year is 100266
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Shares in issue, where the first year is 10042,448
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.